Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markku Laakso

Showing results (1-10 of 620) with videos related to

Pageof 62
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|September 18, 2008
Diabetes as a 'cardiovascular disease equivalent': implications for treatmentMarkku Laakso
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|July 15, 2010
Lipid disorders in type 2 diabetesMarkku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|November 21, 2007
[Not Available]Markku Laakso
Current Diabetes Reports|October 14, 2015
Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?Markku Laakso
Seminars in Vascular Medicine|October 14, 2005
Lipids in type 2 diabetesMarkku Laakso
Diabetes Care|January 28, 2010
Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008Markku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|October 8, 2005
[New criteria and care for metabolic syndrome]Markku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|November 10, 2006
[Not Available]Markku Laakso
Molecular Metabolism|September 11, 2019
Biomarkers for type 2 diabetesMarkku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|December 3, 2003
[Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?]Markku Laakso
Pageof 62

Showing results (1-10 of 620) with videos related to

Sort By:
Pageof 62
Nature Clinical Practice. Cardiovascular Medicine|September 18, 2008
Diabetes as a 'cardiovascular disease equivalent': implications for treatmentMarkku Laakso
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|July 15, 2010
Lipid disorders in type 2 diabetesMarkku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|November 21, 2007
[Not Available]Markku Laakso
Current Diabetes Reports|October 14, 2015
Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?Markku Laakso
Seminars in Vascular Medicine|October 14, 2005
Lipids in type 2 diabetesMarkku Laakso
Diabetes Care|January 28, 2010
Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008Markku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|October 8, 2005
[New criteria and care for metabolic syndrome]Markku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|November 10, 2006
[Not Available]Markku Laakso
Molecular Metabolism|September 11, 2019
Biomarkers for type 2 diabetesMarkku Laakso
Duodecim; Laaketieteellinen Aikakauskirja|December 3, 2003
[Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?]Markku Laakso
Pageof 62